{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:38:11Z","timestamp":1792539491951,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Real-world epidemiological and longitudinal outcome data on autosomal dominant polycystic kidney disease (ADPKD) remain limited in underrepresented populations, including T\u00fcrkiye. We aimed to characterize the epidemiology, regional distribution, and renal outcomes of ADPKD in a large multicenter national cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective multicenter study, adult patients with ADPKD were identified across tertiary nephrology centers in six regions of T\u00fcrkiye (2010\u20132025). Study-based prevalence was calculated using Turkish Statistical Institute population data. Longitudinal renal outcomes were evaluated using serial eGFR measurements and Cox regression models identified predictors of \u2265\u200940% eGFR decline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 2361 patients were included (mean age 38.6\u2009\u00b1\u200914 years; 51.8% female). Median province-level study-based prevalence was 3.86 per 100,000 population (IQR 2.92\u20135.49), with substantial regional variation, highest in the Black Sea region (13.46 per 100,000). Study-based prevalence increased significantly over time (annual percent change 14.4%; 95% CI 13.1\u201315.6;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). During a median follow-up of 6 years, 23.9% experienced a\u2009\u2265\u200940% eGFR decline and 10.5% progressed to kidney failure (eGFR &lt;\u200915 ml\/min\/1.73m2). Median annual eGFR decline was \u2212\u20093.33 mL\/min\/1.73 m\u00b2\/year. In multivariable analysis, age (adjusted HR 1.02; 95% CI 1.00\u20131.03; p\u2009=\u20090.010) and hypertension (adjusted HR 2.33; 95% CI 1.25\u20134.32; p\u2009=\u20090.007) were independently associated with renal progression, whereas tolvaptan use was associated with a lower risk of progression (adjusted HR 0.56; 95% CI 0.37\u20130.85; p\u2009=\u20090.004). The Mayo Imaging Classification remained independently predictive of renal outcomes (p\u2009=\u20090.027).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This large real-world multicenter cohort highlights the geographically heterogeneous study-based burden of ADPKD across participating regions of T\u00fcrkiye. Increasing prevalence over time likely reflects improved disease recognition, whereas the relatively low study-based prevalence suggests persistent under-recognition of ADPKD. These findings provide important longitudinal outcome data from an underrepresented population and support the need for earlier detection and improved risk stratification in ADPKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-026-05217-0","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T09:05:03Z","timestamp":1784883903000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-world epidemiology and renal outcomes of ADPKD in T\u00fcrkiye: the PKD-TURK cohort"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7635-2382","authenticated-orcid":false,"given":"Serpil Muge","family":"Deger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2708-3470","authenticated-orcid":false,"given":"Necmi","family":"Eren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3984-4043","authenticated-orcid":false,"given":"Sibel Yucel","family":"Kocak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0770-1283","authenticated-orcid":false,"given":"Gulay Ulusal","family":"Okyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4157-4513","authenticated-orcid":false,"given":"Beyhan","family":"G\u00fcvercin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5941-9103","authenticated-orcid":false,"given":"Abdulmecit","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3790-1059","authenticated-orcid":false,"given":"Halime Soyak","family":"Kabaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2631-6532","authenticated-orcid":false,"given":"Sabahat Alisir","family":"Ecder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1529-1790","authenticated-orcid":false,"given":"Tahsin","family":"Karaaslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7894-8913","authenticated-orcid":false,"given":"Ayca","family":"Inci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9322-5844","authenticated-orcid":false,"given":"Mehmet Asi","family":"Oktan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7499-1738","authenticated-orcid":false,"given":"Mine Sebnem","family":"Karakan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4449-8266","authenticated-orcid":false,"given":"Asil","family":"Demirezen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9741-6779","authenticated-orcid":false,"given":"Ulver Boztepe","family":"Derici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9588-4803","authenticated-orcid":false,"given":"Bartu","family":"Ediz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5607-1375","authenticated-orcid":false,"given":"Ilhan","family":"Kurultak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8412-1584","authenticated-orcid":false,"given":"Bulent","family":"Huddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6339-8648","authenticated-orcid":false,"given":"Ozlem","family":"Usalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4558-2152","authenticated-orcid":false,"given":"Ilker","family":"Atay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2290-3342","authenticated-orcid":false,"given":"Aysun","family":"Toraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5787-1048","authenticated-orcid":false,"given":"Haci Hasan","family":"Yeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3866-2838","authenticated-orcid":false,"given":"Kursad","family":"Onec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6228-8829","authenticated-orcid":false,"given":"Alper","family":"Azak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0245-1844","authenticated-orcid":false,"given":"Kenan","family":"Turgutalp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3235-0577","authenticated-orcid":false,"given":"Belda","family":"Dursun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1958-7617","authenticated-orcid":false,"given":"Onur","family":"Tunca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7290-4680","authenticated-orcid":false,"given":"Sinan","family":"Kazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2863-7882","authenticated-orcid":false,"given":"Tulin","family":"Akagun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2693-1167","authenticated-orcid":false,"given":"Saliha","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8271-1831","authenticated-orcid":false,"given":"Emre","family":"Yasar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2867-6937","authenticated-orcid":false,"given":"Hulya","family":"Colak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6471-3112","authenticated-orcid":false,"given":"Hayri Ustun","family":"Arda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5416-2257","authenticated-orcid":false,"given":"Selma","family":"Alagoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3569-6269","authenticated-orcid":false,"given":"Hamad","family":"Dheir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8164-6302","authenticated-orcid":false,"given":"Musa","family":"Pinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7493-7179","authenticated-orcid":false,"given":"Ramazan","family":"Danis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2551-4767","authenticated-orcid":false,"given":"Eren","family":"Eynel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9134-7541","authenticated-orcid":false,"given":"Berna","family":"Yelken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2445-1477","authenticated-orcid":false,"given":"Gursel","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0128-3244","authenticated-orcid":false,"given":"Funda","family":"Sari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3448-0490","authenticated-orcid":false,"given":"Serkan","family":"Bakirdogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4697-4815","authenticated-orcid":false,"given":"Bulent","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8720-1400","authenticated-orcid":false,"given":"Ozgur","family":"Can","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6623-9669","authenticated-orcid":false,"given":"Melike Betul","family":"Ogutmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0706-6550","authenticated-orcid":false,"given":"Metin","family":"Ergul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3325-5993","authenticated-orcid":false,"given":"Sibel Gokcay","family":"Bek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3394-5775","authenticated-orcid":false,"given":"Tevfik","family":"Ecder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"11","key":"5217_CR1","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1093\/ndt\/gfz174","volume":"34","author":"KJ Jager","year":"2019","unstructured":"Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C. A single number for advocacy and communication\u2014worldwide more than 850 million individuals have kidney disease. Nephrol Dial Transpl. 2019;34(11):1803\u20135.","journal-title":"Nephrol Dial Transpl"},{"key":"5217_CR2","unstructured":"International Society of Nephrology. ISN Global Kidney Health Atlas 2023. Available from: https:\/\/gkha.theisn.org."},{"issue":"19","key":"5217_CR3","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1001\/jama.2025.0310","volume":"333","author":"FT Chebib","year":"2025","unstructured":"Chebib FT, Hanna C, Harris PC, Torres VE, Dahl NK. Autosomal dominant polycystic kidney disease: a review. JAMA. 2025;333(19):1708\u201319.","journal-title":"JAMA"},{"issue":"9569","key":"5217_CR4","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","volume":"369","author":"VE Torres","year":"2007","unstructured":"Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet. 2007;369(9569):1287\u2013301.","journal-title":"Lancet"},{"issue":"10","key":"5217_CR5","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1681\/ASN.2018050493","volume":"29","author":"MB Lanktree","year":"2018","unstructured":"Lanktree MB, Haghighi A, Guiard E, Iliuta IA, Song X, Harris PC, et al. Prevalence estimates of polycystic kidney and liver disease by population sequencing. J Am Soc Nephrol. 2018;29(10):2593\u2013600.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"5217_CR6","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1093\/ndt\/gfq656","volume":"26","author":"G Suleymanlar","year":"2011","unstructured":"Suleymanlar G, Uta\u015f C, Arinsoy T, Ates K, Altun B, Altiparmak MR, et al. A population-based survey of chronic renal disease in Turkey\u2014the CREDIT study. Nephrol Dial Transpl. 2011;26(6):1862\u201371.","journal-title":"Nephrol Dial Transpl"},{"issue":"2","key":"5217_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.5152\/turkjnephrol.2026.261346","volume":"35","author":"N Seyahi","year":"2026","unstructured":"Seyahi N, Kocyigit I, Dincer MT, Eren N, Tonbul HZ, Tatar E, et al. Current Status of Kidney Replacement Therapy in T\u00fcrkiye: A Summary of 2024 Turkish Society of Nephrology Registry Report. Turk J Nephrol. 2026;35(2):163\u201370.","journal-title":"Turk J Nephrol"},{"key":"5217_CR8","doi-asserted-by":"publisher","unstructured":"Hoekstra MW, Boenink R, Bonthuis M, Boerstra BA, Astley ME, Montez de Sousa IR et al. The ERA Registery Annual Report2023: Epidemiology of kidney replacement therapy in Europe, with a focus on age comparisons. Clin Kidney J sfag036. https:\/\/doi.org\/10.1093\/ckj\/sfag036.","DOI":"10.1093\/ckj\/sfag036"},{"key":"5217_CR9","unstructured":"World Health Organization. International statistical classification of diseases and related health problems, 10th Revision (ICD-10). Geneva: WHO."},{"issue":"9","key":"5217_CR10","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"19","key":"5217_CR11","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya NA, Coresh J, Tighiouart H, Wang D, Sang Y, et al. New creatinine-and-cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737\u201349.","journal-title":"N Engl J Med"},{"key":"5217_CR12","unstructured":"KDIGO. 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1\u2013150."},{"issue":"1","key":"5217_CR13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1681\/ASN.2013101138","volume":"26","author":"MV Irazabal","year":"2015","unstructured":"Irazabal MV, Rangel LJ, Bergstralh EJ, Osborn SL, Harmon AJ, Sundsbak JL, et al. Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials. J Am Soc Nephrol. 2015;26(1):160\u201372.","journal-title":"J Am Soc Nephrol"},{"issue":"20","key":"5217_CR14","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1056\/NEJMoa054341","volume":"354","author":"JJ Grantham","year":"2006","unstructured":"Grantham JJ, Torres VE, Chapman AB, Guay-Woodford LM, Bae KT, King BF, et al. Volume progression in polycystic kidney disease. N Engl J Med. 2006;354(20):2122\u201330.","journal-title":"N Engl J Med"},{"key":"5217_CR15","unstructured":"Turkish Statistical Institute (T\u00dc\u0130K). Population statistics 2025. Available from: https:\/\/data.tuik.gov.tr\/."},{"issue":"24","key":"5217_CR16","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1001\/jama.2014.6634","volume":"311","author":"J Coresh","year":"2014","unstructured":"Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA. 2014;311(24):2518\u201331.","journal-title":"JAMA"},{"issue":"8","key":"5217_CR17","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1093\/ndt\/gfw240","volume":"32","author":"CJ Willey","year":"2017","unstructured":"Willey CJ, Blais JD, Hall AK, Krasa HB, Makin AJ, Czerwiec FS. Prevalence of autosomal dominant polycystic kidney disease in the European Union. Nephrol Dial Transpl. 2017;32(8):1356\u201363.","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"5217_CR18","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1053\/j.ajkd.2011.01.023","volume":"57","author":"C Patch","year":"2011","unstructured":"Patch C, Charlton J, Roderick PJ, Gulliford MC. Use of antihypertensive medications and mortality of patients with autosomal dominant polycystic kidney disease: a population-based survey. Am J Kidney Dis. 2011;57(6):856\u201362.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"5217_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1681\/ASN.2017050483","volume":"29","author":"E Cornec-Le Gall","year":"2018","unstructured":"Cornec-Le Gall E, Torres VE, Harris PC. Genetic complexity of autosomal dominant polycystic kidney and liver disease. J Am Soc Nephrol. 2018;29(1):13\u201323.","journal-title":"J Am Soc Nephrol"},{"issue":"Supp 4","key":"5217_CR20","doi-asserted-by":"publisher","first-page":"iv15","DOI":"10.1093\/ndt\/gfu017","volume":"29","author":"EM Spithoven","year":"2014","unstructured":"Spithoven EM, Kramer A, Meijer E, Orskov B, Wanner C, Abad JM, et al. Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival -an analysis data from the ERA-EDTA Registry. Nephrol Dial Transpl. 2014;29(Supp 4):iv15\u201325.","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"5217_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/1744-9987.13860","volume":"27","author":"E Dogan","year":"2023","unstructured":"Dogan E, Eren N, Ozcan SG, Altunoren O, Gungor O, Dheir H, et al. Relationship between disease awareness and severity of kidney disease in autosomal dominant polycystic kidney disease patients. Ther Apher Dial. 2023;27(1):117\u201322.","journal-title":"Ther Apher Dial"},{"issue":"24","key":"5217_CR22","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMoa1402685","volume":"371","author":"RW Schrier","year":"2014","unstructured":"Schrier RW, Abebe KZ, Perrone RD, Torres VE, Braun WE, Steinman TI, et al. Blood pressure in early autosomal dominant polycystic kidney disease. N Engl J Med. 2014;371(24):2255\u201366.","journal-title":"N Engl J Med"},{"issue":"1","key":"5217_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1573402111309010002","volume":"9","author":"T Ecder","year":"2013","unstructured":"Ecder T. Cardiovascular complications in autosomal dominant polycystic kidney disease. Curr Hypertens Rev. 2013;9(1):2\u201311.","journal-title":"Curr Hypertens Rev"},{"issue":"24","key":"5217_CR24","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1056\/NEJMoa1402686","volume":"371","author":"VE Torres","year":"2014","unstructured":"Torres VE, Abebe KZ, Chapman AB, Schrier RW, Braun WE, Steinman TI, et al. Angiotensin blockade in late autosomal dominant polycystic kidney disease. N Engl J Med. 2014;371(24):2267\u201376.","journal-title":"N Engl J Med"},{"issue":"2","key":"5217_CR25","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1053\/j.ajkd.2020.12.020","volume":"78","author":"FT Chebib","year":"2021","unstructured":"Chebib FT, Torres VE. Assessing risk of rapid progression in autosomal dominant polycystic kidney disease and special considerations for disease-modifying therapy. Am J Kidney Dis. 2021;78(2):282\u201392.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"5217_CR26","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1681\/ASN.2012070650","volume":"24","author":"E Cornec-Le Gall","year":"2013","unstructured":"Cornec-Le Gall E, Audr\u00e9zet MP, Chen JM, Hourmant M, Morin MP, Perrichot R, et al. Type of PKD1 mutation influences renal outcome in ADPKD. J Am Soc Nephrol. 2013;24(6):1006\u201313.","journal-title":"J Am Soc Nephrol"},{"issue":"25","key":"5217_CR27","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"VE Torres","year":"2012","unstructured":"Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012;367(25):2407\u201318.","journal-title":"N Engl J Med"},{"issue":"20","key":"5217_CR28","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","volume":"377","author":"VE Torres","year":"2017","unstructured":"Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Perrone RD, Koch G, et al. Tolvaptan in later-stage autosomal dominant polycystic kidney disease. N Engl J Med. 2017;377(20):1930\u201342.","journal-title":"N Engl J Med"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05217-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05217-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05217-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T22:39:53Z","timestamp":1792535993000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05217-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5217"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05217-0","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"15 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Dokuz Eyl\u00fcl University Non-Interventional Clinical Research Ethics Committee (Approval No. 2025\/03\u201322) and conducted in accordance with the Declaration of Helsinki. Owing to the retrospective design of the study, the requirement for informed consent was waived by the Dokuz Eylul University Non-Interventional Clinical Research Ethics Committee.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"622"}}